Hepatitis C screening in community pharmacies—A feasibility and knowledge transfer study: PHARMA-C
HCV point-of-care testing by CPs is feasible in Quebec. Expanding pharmacists' scope of practice to include HCV screening and increasing pharmacists' role in the HCV care cascade is encouraged in order to further efforts toward HCV elimination.
Authors
- Dominic Martel (ORCID: https://orcid.org/0000-0002-8384-8263)
- Abdolvahed Khodamoradi (ORCID: https://orcid.org/0000-0001-7823-1755)
- Valérie Martel‐Laferrière (ORCID: https://orcid.org/0000-0001-7973-8582)
- Rachel Therrien (ORCID: https://orcid.org/0000-0003-4170-017X)
- Frédéric Provost (ORCID: https://orcid.org/0000-0002-2432-7580)
- Nancy L. Sheehan
- Émilie Roy-St-Pierre
- Rose Prévost
- Kamilia Idir
Institutions
- McGill University Health Centre (CA)
- Centre Hospitalier Universitaire Sainte-Justine (CA)
- Centre Hospitalier de l’Université de Montréal (CA)
- Université de Montréal (CA)
Publication Details
- Journal
- Journal of the Association of Medical Microbiology and Infectious Disease Canada
- Published
- 2024-10-25
- DOI
- https://doi.org/10.3138/jammi-2024-0010
- Citations
- 1
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.37
Funders
- Gilead Sciences
- ViiV Healthcare
- Université de Montréal
- Merck Canada